Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1885 1
1886 1
1913 1
1947 1
1956 1
1957 2
1958 3
1959 1
1960 1
1961 6
1962 9
1963 5
1964 3
1965 7
1966 7
1967 9
1968 7
1969 14
1970 6
1971 10
1972 12
1973 17
1974 19
1975 12
1976 26
1977 22
1978 24
1979 22
1980 18
1981 30
1982 28
1983 23
1984 26
1985 15
1986 14
1987 18
1988 20
1989 23
1990 17
1991 24
1992 39
1993 25
1994 39
1995 40
1996 45
1997 26
1998 30
1999 42
2000 50
2001 73
2002 71
2003 82
2004 95
2005 109
2006 174
2007 107
2008 156
2009 216
2010 213
2011 261
2012 338
2013 314
2014 367
2015 391
2016 427
2017 442
2018 445
2019 461
2020 570
2021 699
2022 710
2023 721
2024 727
2025 586

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,582 results

Results by year

Filters applied: . Clear all
Page 1
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Aurivillius M, Reisner C, Dorinsky P; ETHOS Investigators. Rabe KF, et al. Among authors: singh d. N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24. N Engl J Med. 2020. PMID: 32579807 Clinical Trial.
Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.
Yun JH, Lamb A, Chase R, Singh D, Parker MM, Saferali A, Vestbo J, Tal-Singer R, Castaldi PJ, Silverman EK, Hersh CP; COPDGene and ECLIPSE Investigators. Yun JH, et al. Among authors: singh d. J Allergy Clin Immunol. 2018 Jun;141(6):2037-2047.e10. doi: 10.1016/j.jaci.2018.04.010. Epub 2018 Apr 28. J Allergy Clin Immunol. 2018. PMID: 29709670 Free PMC article.
Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS).
Singh D, Martinez FJ, Hurst JR, Han MK, Gale CP, Fredriksson M, Kisielewicz D, Mushunje A, Movitz C, Ojili N, Parikh H, Arya N, Bowen K, Patel M. Singh D, et al. Am J Respir Crit Care Med. 2025 Feb;211(2):205-214. doi: 10.1164/rccm.202312-2311OC. Am J Respir Crit Care Med. 2025. PMID: 39213002 Clinical Trial.
Isoproterenol.
Szymanski MW, Singh DP. Szymanski MW, et al. Among authors: singh dp. 2023 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30252298 Free Books & Documents.
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials.
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Dakin P, Maloney J, Lu X, Bauer D, Bansal A, Abdulai RM, Robinson LB. Bhatt SP, et al. Among authors: singh d. Lancet Respir Med. 2025 Mar;13(3):234-243. doi: 10.1016/S2213-2600(24)00409-0. Epub 2025 Jan 31. Lancet Respir Med. 2025. PMID: 39900091 Clinical Trial.
A phase 2a trial of the IL-33 monoclonal antibody tozorakimab in patients with COPD: FRONTIER-4.
Singh D, Guller P, Reid F, Doffman S, Seppälä U, Psallidas I, Moate R, Smith R, Kiraga J, Jimenez E, Brooks D, Kelly A, Nordenmark LH, Sadiq MW, Caballero LM, Kell C, Belvisi MG, Pandya H. Singh D, et al. Eur Respir J. 2025 Jul 14;66(1):2402231. doi: 10.1183/13993003.02231-2024. Print 2025 Jul. Eur Respir J. 2025. PMID: 40154559 Free PMC article. Clinical Trial.
Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS).
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Dakin P, Maloney J, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM. Bhatt SP, et al. Among authors: singh d. Respir Med. 2025 Jan;236:107846. doi: 10.1016/j.rmed.2024.107846. Epub 2024 Oct 30. Respir Med. 2025. PMID: 39481660 Free article. Clinical Trial.
Extensive tophaceous gout.
Singh D, Joshi RP, Kumar S. Singh D, et al. Indian J Dermatol Venereol Leprol. 2025 Jan 1:1. doi: 10.25259/IJDVL_1336_2024. Online ahead of print. Indian J Dermatol Venereol Leprol. 2025. PMID: 39912166 Free article. No abstract available.
8,582 results